Back to User profile » Professor Shaohang Cai
Papers published by Professor Shaohang Cai:
The Role of Infiltrated T Lymphocyte in Oral Squamous Cell Carcinoma: Insights into Clinicopathological Characteristics and Prognosis
Liao W, Lu J, Xu Y, Yang C, Chen H, Cai S, Liu L, Chen S
Journal of Inflammation Research 2024, 17:2195-2204
Published Date: 11 April 2024
Soluble Programmed Cell Death-1 is a Novel Predictor of HBsAg Loss in Chronic Hepatitis B Patients When Long-Term Nucleos(t)ide Analog Treatment is Discontinued
Liao G, Liu Z, Xia M, Chen H, Wu H, Li B, Yu T, Cai S, Zhang X, Peng J
Infection and Drug Resistance 2022, 15:2347-2357
Published Date: 29 April 2022
aMAP Score as a Predictor for Long-Term Outcomes in Patients with HBV-Related Acute-on-Chronic Liver Failure
Sun Y, Li Z, Liao G, Xia M, Xu X, Cai S, Peng J
International Journal of General Medicine 2022, 15:407-415
Published Date: 10 January 2022
Association Between Nutritional Risk Screening Score and Prognosis of Patients with Sepsis
Gao Q, Cheng Y, Li Z, Tang Q, Qiu R, Cai S, Xu X, Peng J, Xie H
Infection and Drug Resistance 2021, 14:3817-3825
Published Date: 17 September 2021
Hepatitis B Core-Related Antigen is a Biomarker for off-Treatment Relapse After Long-Term Nucleos(t)ide Analog Therapy in Patients with Chronic Hepatitis B
Liao G, Ding X, Xia M, Wu Y, Chen H, Fan R, Zhang X, Cai S, Peng J
International Journal of General Medicine 2021, 14:4967-4976
Published Date: 28 August 2021
Depression, Anxiety, Psychological Symptoms and Health-Related Quality of Life in People Living with HIV
Cai S, Liu L, Wu X, Pan Y, Yu T, Ou H
Patient Preference and Adherence 2020, 14:1533-1540
Published Date: 25 August 2020
Serum Hepatitis B Virus RNA Levels Predict HBeAg Seroconversion and Virological Response in Chronic Hepatitis B Patients with High Viral Load Treated with Nucleos(t)ide Analog
Ji X, Xia M, Zhou B, Liu S, Liao G, Cai S, Zhang X, Peng J
Infection and Drug Resistance 2020, 13:1881-1888
Published Date: 22 June 2020
Risk factors associated with fatigue in chronic hepatitis B patients
Zhong C, Yin J, Zheng Z, Cai S, Gao Y
Patient Preference and Adherence 2019, 13:1065-1072
Published Date: 4 July 2019
Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B
Zheng C, Yan H, Zeng J, Cai S, Wu X
Infection and Drug Resistance 2019, 12:845-854
Published Date: 12 April 2019
Altered epidermal fatty acid-binding protein expression in hepatocellular carcinoma predicts unfavorable outcomes
Lu J, Cai S, Pan Y, Yun J
Cancer Management and Research 2018, 10:6275-6284
Published Date: 23 November 2018
A model combining TNM stage and tumor size shows utility in predicting recurrence among patients with hepatocellular carcinoma after resection
Zhang Y, Chen S, Liu L, Yang X, Cai S, Yun J
Cancer Management and Research 2018, 10:3707-3715
Published Date: 20 September 2018
Decreased expression of peroxisome proliferator-activated receptor alpha indicates unfavorable outcomes in hepatocellular carcinoma
Xiao YB, Cai SH, Liu LL, Yang X, Yun JP
Cancer Management and Research 2018, 10:1781-1789
Published Date: 26 June 2018
Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs
Cai S, Li Z, Yu T, Xia M, Peng J
Infection and Drug Resistance 2018, 11:469-477
Published Date: 3 April 2018
Health-related quality of life in patients with chronic hepatitis B during antiviral treatment and off-treatment
Xue X, Cai S, Ou H, Zheng C, Wu X
Patient Preference and Adherence 2017, 11:85-93
Published Date: 12 January 2017